RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

Rhea-AI Summary

RxSight (RXST), an ophthalmic medical device company focused on customized vision solutions for post-cataract surgery patients, has announced it will release its fourth quarter 2024 financial results on February 25, 2025, after market close. The company will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results. Investors can join via phone at (800) 715-9871 or (646) 307-1963 using conference code 7159871, or listen to the webcast through the company's investor relations website. A recording will be available after the call.

ALISO VIEJO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter of 2024 after the market close on Tuesday, February 25, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 7159871. The call will also be broadcast live in listen-only mode via a link on the company’s investor relations website at https://investors.rxsight.com/. An archived recording of the call will be available through the same link shortly after its completion.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com

FAQ

When will RxSight (RXST) release Q4 2024 earnings?

RxSight (RXST) will release its Q4 2024 earnings on February 25, 2025, after market close.

What time is RxSight's (RXST) Q4 2024 earnings call?

RxSight's Q4 2024 earnings call is scheduled for 1:30 PM Pacific Time / 4:30 PM Eastern Time on February 25, 2025.

How can investors access RxSight's (RXST) Q4 2024 earnings call?

Investors can access the call by dialing (800) 715-9871 or (646) 307-1963 with conference code 7159871, or listen to the webcast at investors.rxsight.com.

Will RxSight (RXST) provide a replay of their Q4 2024 earnings call?

Yes, RxSight will make an archived recording of the call available through their investor relations website shortly after its completion.